Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04XZE
|
||||
Former ID |
DNC001582
|
||||
Drug Name |
NS-7
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nerve injury [ICD10:T14.4] | Phase 2 | [525754] | ||
Therapeutic Class |
Analgesics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H29N3O4S2
|
||||
Canonical SMILES |
CC1=C(C=C2C(=C1)CC(NS2(=O)=O)C3CCCC3)S(=O)(=O)N4CCN(CC4<br />)C
|
||||
InChI |
1S/C19H29N3O4S2/c1-14-11-16-12-17(15-5-3-4-6-15)20-27(23,24)19(16)13-18(14)28(25,26)22-9-7-21(2)8-10-22/h11,13,15,17,20H,3-10,12H2,1-2H3/t17-/m1/s1
|
||||
InChIKey |
KQAGZLQCEURCKJ-QGZVFWFLSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Modulator | [525754] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.